Bretley Sitzman
Pain Medicine · Hattiesburg, MSNPI 1295845311
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (59.2%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. 26 manufacturers reported payments, led by Pfizer at 55.6% of the total. Reporting peaked in 2019 at $10,276 and has fallen 98.2% since, to $180 in 2025. Among pain medicine clinicians in MS with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 136 payments — averaging $131.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$10K
- Lilly USA, LLC$4K
- Medtronic$1K
- Vertiflex, Inc.$1K
- Nevro Corp.$403
- Stimwave Technologies Incorporated$220
- plus $1K from 20 others
What the payments were for
- Consulting fees$10,62059%
- Speaking & faculty fees$2,75015%
- Travel & lodging$1,1116%
- Food & beverage$3,44419%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 26 | $9,957 |
| Lilly USA, LLC | 1 | $3,600 |
| Medtronic(2 entities) | 27 | $1,259 |
| Vertiflex, Inc. | 8 | $1,226 |
| Nevro Corp. | 21 | $403 |
| Stimwave Technologies Incorporated | 2 | $220 |
| Stryker | 2 | $174 |
| Biodelivery Sciences International, Inc. | 11 | $174 |
| Boston Scientific | 5 | $131 |
| Si-bone, Inc. | 1 | $130 |
| Collegium Pharmaceutical, Inc. | 8 | $128 |
| Abbott | 1 | $120 |
| Pacira Therapeutics, Inc. | 6 | $112 |
| Vertex | 2 | $50 |
| Nalu Medical, Inc. | 2 | $39 |
| Bioventus LLC | 2 | $33 |
| Scilex Pharmaceuticals Inc. | 2 | $30 |
| Arbor Pharmaceuticals, Inc. | 1 | $22 |
| Daiichi Sankyo Inc. | 1 | $19 |
| Redhill Biopharma Inc. | 1 | $17 |
| Tersera Therapeutics LLC | 1 | $17 |
| Spinal Simplicity, LLC | 1 | $15 |
| Pernix Therapeutics Holdings, Inc. | 1 | $14 |
| Piramal Critical Care | 1 | $14 |
| Electronic Waveform Lab, Inc. | 1 | $13 |
| Forte Bio-pharma LLC | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Superion ISS$1,047
- INTELLIS$538
- Eon Family of SCS IPGs$120
How this compares
$17,925 in reported general payments places this provider in the 90th percentile of 48 pain medicine providers in Mississippi.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xtampza ErOxycodone Myristate | 53 | $61,829 |
| Fentanyl | 318 | $52,058 |
| OxycontinOxycodone Hcl | 27 | $27,003 |
| Morphine Sulfate ErMorphine Sulfate | 517 | $16,390 |
| LinzessLinaclotide | 27 | $13,286 |
| Hysingla ErHydrocodone Bitartrate | 13 | $12,595 |
| Oxycodone Hcl | 476 | $10,334 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 545 | $9,420 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 286 | $7,802 |
| Gabapentin | 397 | $4,992 |
| Morphine Sulfate | 85 | $1,993 |
| Tizanidine Hcl | 247 | $1,798 |
| Buprenorphine Hcl | 21 | $1,589 |
| Lidocaine | 14 | $1,317 |
| Pregabalin | 129 | $1,160 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er | $128 | $61,82953 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 48 pain medicine providers in Mississippi.
Other pain medicine in Hattiesburg
- Dennis MarceloHattiesburg$10K
- Jonathan RayburnHattiesburg$8K
- Alan ColeHattiesburg$6K
- Brent BevardHattiesburg$6K
- David McKellarHattiesburg$2K
- Joe LeighHattiesburg$414
- Rayhan TariqLaurel$64K
- Alan TorreyVicksburg$30K
- Landon BurnsFlowood$22K
- Joe CookByram$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.